Analysis of Letrozole in Patients With Operable Hormone Receptor Positive, HER2 Negative Breast Cancer

NCT05447910 · clinicaltrials.gov ↗

TERMINATED

Status

21

Enrollment

OTHER

Sponsor class

Stopped insufficient funding

Conditions

Breast Adenocarcinoma
Invasive Breast Carcinoma
Resectable Breast Carcinoma

Interventions

PROCEDURE: Biospecimen Collection

Sponsor

Mayo Clinic